Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in ANIK — Anika Therapeutics, Inc.

CIK 1109448 NASHVILLE, TN
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$320,543
+$24,018 QoQ
Shares Held
21,910
+7.1% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $485,105,474 across 44 Drug Manufacturers - Specialty & Generic names. ANIK ranks #36 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 234,607 $127,117,110
2 NBIX
Neurocrine Biosciences Inc
 461,270 $77,742,445
3 RDY
Dr Reddys Laboratories Ltd
 3,730,713 $54,058,031
4 ZTS
Zoetis Inc.
 698,452 $50,190,760
5 KNSA
Kiniksa Pharmaceuticals International, plc
 556,151 $35,565,856
6 VTRS
Viatris Inc
 1,233,234 $19,583,755
7 ELAN
Elanco Animal Health Inc
 621,675 $15,299,421
8 HIMS
Hims & Hers Health, Inc.
 438,863 $15,215,380

All Filings in ANIK

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $320,543 21,910
2026-03-31 $296,525 20,450
2025-12-31 $196,524 20,450
2025-09-30 $192,230 20,450
2025-06-30 $216,361 20,450
2025-03-31 $289,327 19,250
2024-12-31 $316,855 19,250
2024-09-30 $475,475 19,250
2024-06-30 $487,602 19,250
2024-03-31 $477,520 18,800
2023-12-31 $426,008 18,800
2023-09-30 $350,244 18,800
2023-06-30 $488,424 18,800
2023-03-31 $539,936 18,800
2022-12-31 $620,297 20,956
2022-09-30 $472,215 19,841
2022-06-30 $442,270 19,815
2022-03-31 $496,650 19,779
2021-12-31 $707,929 19,758
2021-09-30 $838,432 19,700
2021-06-30 $882,250 20,380
2021-03-31 $948,693 23,258
2020-12-31 $902,937 19,950
2020-09-30 $801,583 22,650
2020-06-30 $853,452 22,620
2020-03-31 $656,257 22,700